Alnylam Pharmaceuticals
ALNY
#569
Rank
NZ$71.22 B
Marketcap
NZ$537.04
Share price
-1.51%
Change (1 day)
27.09%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company